About Us

Connecticut-based start up LambdaVision Inc. is taking a different approach to restoring vision by developing a flexible, protein-based retinal implant designed to provide higher resolution and to be less surgically invasive than competing technologies. The company, launched by the University of Connecticut R&D Corp. in 2009, was founded to develop and commercialize a protein-based artificial retina utilizing the photoactive proteins bacteriorhodopsin (BR) and halorhodopsin (HR)